Additional file 1. Figure S1. Acquisition of candidate genes and their expression patterns across three tumor molecular subtypes. (A) KEGG analysis revealed the enriched pathways for up-regulated genes in tumor tissues. (B) KEGG analysis revealed the enriched pathways for down-regulated genes in tumor tissues. (C) Forest map shows the correction between the candidate genes and prognosis. (D) Heatmap shows that expression patterns of 24 prognosis-related IRGs among distinct tumor molecular subtypes. The Inf_Clusters (3 molecular subtypes), age, sex, EGFR mutation, N, T, TNM stage were used as patient annotations. Figure S2. The biological characteristics and immune infiltration across the three tumor molecular subtypes. (A, B) Unsupervised c...
Additional file 1: Fig. S1. The relationship between IWHMB and clinical stage, metastasis, smoking, ...
Table S1. Comparison of regulatory T cell marker genes expression levels between the lower-TMB and t...
TCGA LUAD RNAseq − stage I and II ESLA − 7, DFS. Figure S1B: TCGA LUAD RNAseq − stage I and II ESLA ...
Additional file 3. Table S2. GSVA enrichment analysis showing the activation states of biological pa...
Additional file 4. Table S3. The overlapping differentially expressed genes (DEGs) among the three t...
Additional file 7. Table S6. Analysis of differential gene expression between high and low IRGS grou...
Additional file 6. Table S5. The correlation of FDA approved drugs Z scores with the IRG expression ...
Additional file 1: Figure S1. Identification of ICDRS prognostic value in lung adenocarcinoma (LUAD)...
Additional file 5. Table S4. Multivariate Cox analysis (stepwise regression models) for the construc...
Figure S1. Functional categorization based on Gene Ontology (GO) and KEGG pathway analysis. Function...
Table S1. Clinical characteristics. Table S2. RNA-seq gene function list. Table S3. Gene function an...
Supplementary information. Figure A Internal power simulation across various disease-model settings ...
BackgroundImmune-related subgroup classification in immune checkpoint blockade (ICB) therapy is larg...
BackgroundImmune-related subgroup classification in immune checkpoint blockade (ICB) therapy is larg...
BackgroundImmune-related subgroup classification in immune checkpoint blockade (ICB) therapy is larg...
Additional file 1: Fig. S1. The relationship between IWHMB and clinical stage, metastasis, smoking, ...
Table S1. Comparison of regulatory T cell marker genes expression levels between the lower-TMB and t...
TCGA LUAD RNAseq − stage I and II ESLA − 7, DFS. Figure S1B: TCGA LUAD RNAseq − stage I and II ESLA ...
Additional file 3. Table S2. GSVA enrichment analysis showing the activation states of biological pa...
Additional file 4. Table S3. The overlapping differentially expressed genes (DEGs) among the three t...
Additional file 7. Table S6. Analysis of differential gene expression between high and low IRGS grou...
Additional file 6. Table S5. The correlation of FDA approved drugs Z scores with the IRG expression ...
Additional file 1: Figure S1. Identification of ICDRS prognostic value in lung adenocarcinoma (LUAD)...
Additional file 5. Table S4. Multivariate Cox analysis (stepwise regression models) for the construc...
Figure S1. Functional categorization based on Gene Ontology (GO) and KEGG pathway analysis. Function...
Table S1. Clinical characteristics. Table S2. RNA-seq gene function list. Table S3. Gene function an...
Supplementary information. Figure A Internal power simulation across various disease-model settings ...
BackgroundImmune-related subgroup classification in immune checkpoint blockade (ICB) therapy is larg...
BackgroundImmune-related subgroup classification in immune checkpoint blockade (ICB) therapy is larg...
BackgroundImmune-related subgroup classification in immune checkpoint blockade (ICB) therapy is larg...
Additional file 1: Fig. S1. The relationship between IWHMB and clinical stage, metastasis, smoking, ...
Table S1. Comparison of regulatory T cell marker genes expression levels between the lower-TMB and t...
TCGA LUAD RNAseq − stage I and II ESLA − 7, DFS. Figure S1B: TCGA LUAD RNAseq − stage I and II ESLA ...